...
首页> 外文期刊>Frontiers in Immunology >Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
【24h】

Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation

机译:自身免疫性淋巴细胞增生综合征-FAS患者具有异常的调节性T细胞(Treg)表型,但对T细胞增殖显示正常的天然Treg抑制功能

获取原文
           

摘要

Objective Autoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS. Results The proportion of CD25~(high)CD127~(low)Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3~(+)CD4~(+)T cells from ALPS patients and thus an abnormally low proportion of CD25~(high)FOXP3~(+)Helios~(+)T cells. The ALPS patients also displayed a high proportion of na?ve Treg (FOXP3~(low)CD45RA~(+)) and an unusual subpopulation (CD4~(+)CD127~(low)CD15s~(+)CD45RA~(+)). Despite this abnormal phenotype, the CD25~(high)CD127~(low)Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS -mutated patients showed normal levels of sensitivity to Treg suppression. Conclusion An abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro . This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.
机译:目的伴有FAS突变的自身免疫性淋巴组织增生综合征(ALPS-FAS)是一种具有自身免疫性的非恶性,非感染性,淋巴组织增生性疾病。鉴于天然调节性T细胞(nTregs)在控制淋巴细胞增殖和自身免疫中的核心作用,我们评估了16名ALPS-FAS患者的nTreg抑制功能。结果ALPS-FAS患者的CD25〜(高)CD127〜(低)Tregs比例低于健康人。该亚群与来自ALPS患者的CD3〜(+)CD4〜(+)T细胞中CD25表达降低有关,因此与CD25〜(高)FOXP3〜(+)Helios〜(+)T细胞异常低比例相关。 ALPS患者还表现出高比例的幼稚Treg(FOXP3〜(low)CD45RA〜(+))和不寻常的亚群(CD4〜(+)CD127〜(low)CD15s〜(+)CD45RA〜(+) )。尽管存在这种异常表型,但CD25〜(高)CD127〜(低)Tregs的抑制功能并未受到影响。此外,来自FAS突变患者的常规T细胞显示出正常水平的Treg抑制敏感性。结论ALPS患者循环淋巴细胞中Treg表型异常。然而,这些Treg在体外对T效应子增殖显示出正常的抑制功能。这表明在ALPS患者中观察到的淋巴细胞增殖不是由Tregs功能缺陷或T效应细胞对Tregs抑制不敏感引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号